Date | Time | Source | Announcement |
---|---|---|---|
25 Apr 2008 | 09:02 AM | 2008 Investment Show | |
22 Apr 2008 | 10:18 AM | Annual Report and Accounts | |
14 Mar 2008 | 07:01 AM | Preliminary Results | |
07 Mar 2008 | 07:01 AM | Conference presentation | |
22 Feb 2008 | 12:23 PM | Major Interest in Shares | |
09 Jan 2008 | 07:00 AM | Trading Update | |
04 Oct 2007 | 02:35 PM | Director of Share Purchase | |
12 Sep 2007 | 01:28 PM | Director Share Purchase | |
12 Sep 2007 | 07:01 AM | Interim Results | |
31 Aug 2007 | 05:21 PM | Major Interest in Shares | |
31 Aug 2007 | 08:36 AM | Major Interest in Shares | |
13 Aug 2007 | 10:45 AM | AIM Rule 26 | |
27 Jul 2007 | 11:20 AM | Grant of Options | |
23 Jul 2007 | 07:00 AM | Positive Isprelor Results | |
11 Jul 2007 | 07:00 AM | Half Year Trading Update | |
28 Jun 2007 | 07:01 AM | Appt of Finance Director | |
13 Jun 2007 | 07:01 AM | Cost Control Programme | |
16 May 2007 | 09:58 AM | AGM Statement | |
22 Mar 2007 | 07:01 AM | Forceval China Rights | |
22 Mar 2007 | 07:01 AM | Preliminary Results | |
27 Feb 2007 | 07:00 AM | Notification of Shares | |
19 Feb 2007 | 01:56 PM | Notification of Shares | |
15 Jan 2007 | 07:00 AM | Trading and Product Update | |
10 Jan 2007 | 07:00 AM | Board Appointment | |
19 Dec 2006 | 04:45 PM | Transparency Directive | |
23 Oct 2006 | 07:00 AM | Syntometrine Acquisition | |
18 Sep 2006 | 10:01 AM | Director/PDMR Shareholding | |
15 Sep 2006 | 07:00 AM | Product Acquisition | |
13 Sep 2006 | 07:00 AM | Interim Results | |
08 Aug 2006 | 07:00 AM | Notice of Interim Results | |
06 Jul 2006 | 07:00 AM | Pfizer Products Acquisition | |
08 Jun 2006 | 07:00 AM | Appointment | |
22 May 2006 | 07:00 AM | Distribution Agreement | |
18 May 2006 | 02:43 PM | Major Interests in Shares | |
18 May 2006 | 07:00 AM | Dermatology Acquisition | |
17 May 2006 | 07:00 AM | Notification of Interests | |
12 May 2006 | 10:19 AM | AGM Statement | |
10 May 2006 | 07:00 AM | Placing to raise GBP2.5m | |
23 Mar 2006 | 07:01 AM | Preliminary Results | |
21 Mar 2006 | 02:07 PM | Interest in Major Shares | |
02 Mar 2006 | 07:00 AM | Notice of Results | |
09 Feb 2006 | 01:05 PM | Hydromol Acquisition | |
10 Jan 2006 | 07:00 AM | Trading Statement | |
03 Nov 2005 | 07:00 AM | Interim Results | |
03 Nov 2005 | 07:00 AM | Product Disposal | |
11 Oct 2005 | 11:21 AM | Results Notification | |
01 Aug 2005 | 07:00 AM | Notification of Shares | |
29 Jul 2005 | 07:00 AM | Distribution Agreement | |
13 Jul 2005 | 10:11 AM | Notification of Shares | |
06 Jul 2005 | 07:00 AM | Phase III Trials Approval |
Alliance Pharma markets prescription medicines and consumer healthcare products, including Nizoral™ anti-dandruff shampoo and KELO-COTE™ silicone scar treatment.
It operated in 100 countries, including the UK, Ireland, Mainland Europe, the British Virgin Islands, France, the US, and Germany.
Alliance share price launched at 51p in 2001.